BRIEF published on 06/03/2025 at 17:05, 6 months 2 days ago Evotec SE Annual General Meeting 2025 Highlights Drug Discovery Shareholder Decisions Strategic Outlook Evotec 2025 AGM Board Introductions
PRESS RELEASE published on 06/03/2025 at 17:00, 6 months 2 days ago Evotec SE: Results of the Annual General Meeting 2025 Evotec SE shareholders approve proposals at Annual General Meeting 2025, featuring strategic outlook and new Management Board members; 46.45% share capital represented Annual General Meeting Shareholders Evotec SE Management Board Strategic Outlook
BRIEF published on 05/07/2025 at 07:35, 6 months 29 days ago Evotec obtient une subvention de 2,5 millions de dollars pour le développement d'un traitement contre la tuberculose Evotec Santé Mondiale Résistance Aux Médicaments Tuberculose Fondation Gates
BRIEF published on 05/07/2025 at 07:35, 6 months 29 days ago Evotec Secures $2.5 Million Grant for Tuberculosis Treatment Development Evotec Global Health Drug Resistance Tuberculosis Gates Foundation
PRESS RELEASE published on 05/07/2025 at 07:30, 6 months 29 days ago Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE receives $2.5 m grant from Gates Foundation to develop next-generation tuberculosis treatments, focusing on drug combinations to reduce treatment duration and overcome resistance Evotec SE Grant Gates Foundation Tuberculosis Treatments Drug Combinations
BRIEF published on 05/06/2025 at 07:05, 6 months 30 days ago Evotec SE publie ses résultats financiers du premier trimestre 2025 dans un contexte de marché faible Partenariats Stratégiques Perspectives Financières Croissance Des Produits Biologiques Evotec T1 2025 Dégradation Des Protéines
BRIEF published on 05/06/2025 at 07:05, 6 months 30 days ago Evotec SE Reports Q1 2025 Financial Results Amid Soft Market Strategic Partnerships Financial Outlook Biologics Growth Protein Degradation Evotec Q1 2025
PRESS RELEASE published on 05/06/2025 at 07:00, 6 months 30 days ago Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE reports Q1 2025 results, highlighting strategic partnerships & sustainable growth plans in soft market. 2025 guidance and 2028 outlook confirmed Strategic Partnerships Evotec SE Growth Plans Q1 2025 Soft Market
BRIEF published on 04/29/2025 at 10:07, 7 months 6 days ago Evotec SE to Announce Q1 2025 Results on May 6 Financial Results Conference Call Evotec SE Therapeutics Development Webcast Details
BRIEF published on 04/29/2025 at 10:07, 7 months 6 days ago Evotec SE annoncera ses résultats du premier trimestre 2025 le 6 mai Résultats Financiers Evotec SE Conférence Téléphonique Développement Thérapeutique Détails De La Webdiffusion
Published on 12/05/2025 at 21:45, 1 hour 35 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 50 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 2 hours 20 minutes ago The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 22:15, 1 hour 4 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 8 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 22 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 5 hours 4 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 20 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 20 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 20 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 20 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 2 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
